| Ημερομηνία | barcode | code | περιεχομενο | τιμή παραγωγός | χονδρική | λιανική |
|---|---|---|---|---|---|---|
| 05/2018 | 2802971001066 | 297100106 | ETIAPIN F.C.TAB 25MG/TAB BTx60 (BLIST 6x10) | 7.26 | 7.62 | 10.50 |
| 05/2018 | 2802971002056 | 297100205 | ETIAPIN F.C.TAB 100MG/TAB BTx60 (BLIST 6x10) | 13.75 | 14.42 | 19.88 |
| 05/2018 | 2802971003060 | 297100306 | ETIAPIN F.C.TAB 200MG/TAB BTx60 (BLIST 6x10) | 22.65 | 23.76 | 32.74 |
| 05/2018 | 2802971004036 | 297100403 | ETIAPIN F.C.TAB 300MG/TAB BTx30 (BLIST 3x10) | 17.79 | 18.66 | 25.72 |
For the treatment of schizophrenia and related psychotic disorders.
Quetiapine's antipsychotic activity is likely due to a combination of antagonism at D2 receptors in the mesolimbic pathway and 5HT2A receptors in the frontal cortex. Antagonism at D2 receptors relieves positive symptoms while antagonism at 5HT2A receptors relieves negative symptoms of schizophrenia.
Symptoms of overdose include drowsiness and sedation, tachycardia, and hypotension.
Rapidly and well absorbed.
6 hours
Elimination of quetiapine is mainly via hepatic metabolism. Following a single oral dose of 14C-quetiapine, less than 1% of the administered dose was excreted as unchanged drug, indicating that quetiapine is highly metabolized. Approximately 73% and 20% of the dose was recovered in the urine and feces, respectively.
* 10±4 L/kg